The Company
The Company
Promore Pharma in Brief
Vision and Strategy
Market
Team
Board of Directors
Projects
Projects
Project Overview
Ensereptide – Prevention of Post-Surgical Adhesions and Scars
Ropocamptide – Healing of Chronic Wounds
Publications
Investors
Investors
Promore Pharma on Nasdaq First North Growth Market
Certified Adviser
The Share
Shareholders
Warrant Programs
Share capital development
Financial Reports
Press Releases
Prospectuses
Presentations and Events
Calendar
Subscribe
Corporate Governance
Corporate Governance
Corporate Governance
General Meeting
General Meetings
Nomination Committee
Nomination Committees
The Board of Directors
Board of Directors
The Management
Management
Remunerations and Remuneration Committee
Auditor and Audit Committee
Articles of Association
Certificate of Registration
Media
Media
Press Releases
Imagebank
Promore Pharma in Media
Subscribe
Contact
Contact
Office
Investors
Media
Svenska
The Company
Promore Pharma in Brief
Vision and Strategy
Market
Team
Board of Directors
Projects
Project Overview
Ensereptide – Prevention of Scarring
Ropocamptide – Healing of Chronic Wounds
Publications
Investors
Promore Pharma on Nasdaq First North Growth Market
Certified Adviser
The Share
Shareholders
Warrant Programs
Share capital development
Financial Reports
Press Releases
Prospectuses
Presentations and Events
Calendar
Subscribe
Corporate Governance
Corporate Governance
General Meeting
General Meetings
Nomination Committee
Nomination Committees
The Board of Directors
Board of Directors
The Management
Management
Remunerations and Remuneration Committee
Auditor and Audit Committee
Articles of Association
Certificate of Registration
Media
Press Releases
Imagebank
Promore Pharma in Media
Subscribe
Contact
Office
Investors
Media
Investors
Promore Pharma on Nasdaq First North Growth Market
Certified Adviser
The Share
Shareholders
Warrant Programs
Share capital development
Financial Reports
Press Releases
Prospectuses
Presentations and Events
Calendar
Subscribe
Contact
Erik Magnusson
Chief Financial Officer (CFO)
+46 70 856 52 45
Presentations and Events
2021
2020
2019
2018
2017
All years
November 24, 2021
Presentation of Promore Pharma’s Interim report for the third quarter 2021
November 19, 2021
Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2021
August 24, 2021
Presentation of Promore Pharma’s Interim report for the second quarter 2021
August 17, 2021
Invitation to Conference Call regarding Promore Pharma’s Q2 Report 2021
May 28, 2021
Presentation of Promore Pharma’s Interim report for the first quarter 2021
May 26, 2021
Promore Pharma participates in “Småbolagsdagarna 2021”, an event organized by Aktiespararna
May 17, 2021
Invitation to Conference Call regarding Promore Pharma’s Q1 Report 2021
March 31, 2021
Analysis on Promore Pharma: Towards a billion market in bioactive wound care
March 31, 2021
Promore Pharma comments on strategy change
February 24, 2021
Year-end report 2020
February 16, 2021
Invitation to Presentation of Promore Pharma’s Year-end report for 2020
